Oral nutritional supplementation: As directed by the HCP
Study summary
Acceptability, compliance and palatability study.
Eligibility
Sex
ALL
Min age
1 Year
Max age
16 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients from 1-15 years requiring 1 or more oral nutritional supplement to replace current oral nutritional supplement as part of their dietary management for disease related malnutrition.
* Patients well-established and stable on current nutritional support regimen.
* Willingly given, written, informed consent from patient/caregiver.
Exclusion Criteria:
* Unsafe swallow
* Inability to comply with the study protocol, in the opinion of the investigator.
* Under 1 years of age
* Patients on total parenteral nutrition
* Known food allergies, including any allergies to the ingredients
* Patients with Chronic Kidney Disease (CKD) stage 3b (G3b), stage 4 (G4), stage 5 (G5) or hepatic impairment.
* Participation in another interventional study within 2 weeks of this study.
* Patients with known or suspected ileus or mechanical bowel obstruction
Primary outcome measure(s)
Gastrointestinal tolerance — Days 1-7, and at day 14, 21 and 28 Number of children who experienced gastrointestinal symptoms such as reflux, vomiting, nausea, constipation, diarrhoea recorded as a 4 point Likert scale as none, mild, moderate, severe symptoms at baseline and at post switch.
Trial sites (1)
Facility
City
Region
Status
Dietetics
Nottingham
United Kingdom
Recruiting
More Société des Produits Nestlé (SPN) trials in the UK
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.